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background: There is limited data on outcomes after implantation of second generation drug-eluting stents in coronary chronic total occlusions 
(CTOs). Our study’s aim is to evaluate the frequency of angiographic restenosis and clinical outcomes after implantation of the everolimus-eluting 
stent (EES) in CTOs and factors associated with the restenosis risk.
Methods: One hundred patients undergoing successful CTO percutaneous coronary intervention using EES at our institution between 2009 
and 2012 were enrolled. The primary study end point was binary in-segment restenosis at 8-month follow-up quantitative coronary angiography. 
Secondary end points included death, myocardial infarction, target lesion and target vessel revascularization, and symptom improvement.
results: Mean age was 64 ±7 years and 99% of the patients were men. The successful crossing technique was antegrade wiring in 51 patients, 
antegrade dissection/re-entry in 24 patients and retrograde in 25 patients. Binary angiographic restenosis occurred in 46% of the patients (95% 
confidence intervals 35% to 57%). The pattern of restenosis was focal, proliferative, and total occlusion in 19 (46%), 14 (34%), and 8 (20%) lesions, 
respectively. At 12 months the incidence of death, myocardial infarction, and target lesion and vessel revascularization was 2%, 2%, 37% and 39%, 
respectively. At 12 months symptoms were improved, unchanged or worse compared to baseline in 89, 8, and 1 patient respectively (2 patients 
died before the 12 month follow-up). On multivariable analysis only smaller stent diameter was associated with higher risk for binary angiographic 
restenosis [Odds ratio 0.21(95% CI 0,05 to 0.90)].
conclusion: High-rates of angiographic restenosis and repeat revascularization were observed among patients receiving EES in coronary CTOs, but 
most had significant symptom improvement. Smaller stent diameter correlated with higher risk or restenosis.
